JUBBONTI 60 mg/mL
denosumab · INJECTION · Sandoz Inc
No Recall History
Plain English
JUBBONTI is a injection containing denosumab at 60 mg/mL, taken subcutaneous. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- JUBBONTI
- Generic Name
- denosumab
- NDC Code (Product)
61314-240- Manufacturer
- Sandoz Inc
- Strength
- 60 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761362
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 06/02/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
osteonecrosis of jaw1,463 reports
diarrhoea1,097 reports
fatigue1,050 reports
nausea1,022 reports
malignant neoplasm progression995 reports
neutropenia862 reports
metastases to bone797 reports
off label use772 reports
anaemia718 reports
vomiting593 reports
Frequently Asked Questions
What is JUBBONTI used for?
JUBBONTI contains denosumab. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is JUBBONTI a controlled substance?
JUBBONTI is not classified as a controlled substance by the DEA.
What is the generic name for JUBBONTI?
The generic name for JUBBONTI is denosumab. There are 12 other brand versions of denosumab.
What is the NDC code for JUBBONTI 60 mg/mL?
The NDC (National Drug Code) for JUBBONTI 60 mg/mL is 61314-240, listed by Sandoz Inc.